Health Care & Life Sciences » Pharmaceuticals | BioDelivery Sciences International Inc.

BioDelivery Sciences International Inc. | Ownership

Companies that own BioDelivery Sciences International Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Broadfin Capital LLC
5,923,325
9.94%
1,644,506
2.43%
08/14/2018
venBio Select Advisor LLC
5,437,779
9.13%
0
0.55%
06/30/2018
Armistice Capital LLC
3,692,000
6.2%
3,571,111
0.84%
08/06/2018
The Vanguard Group, Inc.
2,360,438
3.96%
15,869
0%
06/30/2018
Royce & Associates LP
2,200,800
3.7%
352,200
0.04%
06/30/2018
Cortina Asset Management LLC
1,908,091
3.2%
1,908,091
0.24%
06/30/2018
Stonepine Capital Management LLC
1,486,002
2.5%
-2,220,082
2.54%
06/30/2018
Ghost Tree Capital LLC
1,411,247
2.37%
1,411,247
1.14%
06/30/2018
BlackRock Fund Advisors
1,180,148
1.98%
30,166
0%
06/30/2018
Columbia Management Investment Advisers LLC
1,112,871
1.87%
-201,210
0%
06/30/2018

About BioDelivery Sciences International

View Profile
Address
4131 ParkLake Avenue
Raleigh North Carolina 27612
United States
Employees -
Website http://www.bdsi.com
Updated 07/08/2019
BioDelivery Sciences International, Inc. is a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. It focuses on pharmaceutical products in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.